Panitumumab Alone for Maintenance Treatment in Advanced Colorectal Cancer

被引：4
|
作者：
Anandappa, Gayathri [1 ,2 ]
Cunningham, David [1 ,2 ]
机构：
[1] Royal Marsden Hosp, Gastrointestinal & Lymphoma Unit, London, England
[2] Royal Marsden Hosp, Gastrointestinal & Lymphoma Unit, Surrey, England
来源：
JAMA ONCOLOGY | 2019年 / 5卷 / 09期
关键词：
CHEMOTHERAPY; BEVACIZUMAB; OXALIPLATIN; THERAPY; TRIAL;
D O I：
10.1001/jamaoncol.2019.1447
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1262 / 1264
页数：3
相关论文
共 50 条
  • [31] Spotlight on Panitumumab in Metastatic Colorectal Cancer
    Gillian M. Keating
    BioDrugs, 2010, 24 : 275 - 278
  • [32] Panitumumab safety for treating colorectal cancer
    Stremitzer, Stefan
    Sebio, Ana
    Stintzing, Sebastian
    Lenz, Heinz-Josef
    EXPERT OPINION ON DRUG SAFETY, 2014, 13 (06) : 843 - 851
  • [33] Spotlight on Panitumumab in Metastatic Colorectal Cancer
    Keating, Gillian M.
    BIODRUGS, 2010, 24 (04) : 275 - 278
  • [34] Colorectal Cancer Panitumumab is not inferior to Cetuximab
    Weiss, Johannes
    ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2014, 52 (09): : 1034 - 1034
  • [35] Panitumumab (Vectibix) for metastatic colorectal cancer
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2007, 49 (1259): : 35 - 36
  • [36] Nipavect: Phase II study of niraparib and panitumumab in advanced RAS WT colorectal cancer
    Alese, Olatunji B.
    Diab, Maria
    Gbolahan, Olumide B.
    McCook-Veal, Ashley
    Shaib, Walid Labib
    Wu, Christina
    Akce, Mehmet
    Liu, Yuan
    Lesinski, Gregory B.
    El-Rayes, Bassel F.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [37] Optimizing Single Agent Panitumumab Therapy in Pre-Treated Advanced Colorectal Cancer
    Gasparini, Giampietro
    Buttitta, Fiamma
    D'Andrea, Mario Rosario
    Tumolo, Salvatore
    Buonadonna, Angela
    Pavese, Ida
    Cordio, Stefano
    De Tursi, Michele
    Mosconi, Stefania
    Stumbo, Luciano
    Felicioni, Lara
    Marchetti, Antonio
    NEOPLASIA, 2014, 16 (09): : 751 - 756
  • [38] Randomized phase II study of maintenance treatment with 5-FU/FA plus panitumumab vs 5-FU/FA alone after induction (mFOLFOX6 plus panitumumab) in patients with RASWT metastatic colorectal cancer
    Modest, D. P.
    Kasper, S.
    Stintzing, S.
    Prasnikar, N.
    Mueller, L.
    Caca, K.
    Goekkurt, E.
    von Weikersthal, L. Fischer
    Kopp, H. -G.
    Trarbach, T.
    ANNALS OF ONCOLOGY, 2016, 27
  • [39] Successful administration of panitumumab alone after severe infusion reaction to cetuximab in a patient with metastatic colorectal cancer
    Cartwright, Thomas H.
    Genther, Renee
    CLINICAL COLORECTAL CANCER, 2008, 7 (03) : 202 - 203
  • [40] The emerging role of Sotorasib plus Panitumumab combination therapy in colorectal cancer treatment
    Kokori, Emmanuel
    Olatunji, Gbolahan
    Ogieuhi, Ikponmwosa Jude
    Ajayi, Yusuf Ismaila
    Akinmoju, Olumide
    Akinboade, Adeola
    Irumudomon, Jessy Grantay
    Omoworare, Oluwatobi Taiwo
    Ezeano, Chimezirim
    Adebayo, Yewande Abigail
    Oyewo, Oluwaseun
    Aderinto, Nicholas
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2025,
12345